Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
11-MULTI-12-OPI/CRAB (11-001) Ph. 1b/II Trial: Carfilzomib w/ Irinotecan in Small Cell LC Pts Who Progressed on prior plat. Chemo
Leggas, Markos
(PI)
Pharmaceutical Sciences
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Irinotecan
100%
Carfilzomib
100%
DNA Topoisomerase
80%
Proteasome
60%
Biological Marker
40%
Clinical Trial
20%
Clinical Study
20%
Chymotrypsin
20%
Medicine and Dentistry
Irinotecan
100%
Carfilzomib
100%
Topoisomerase
80%
Proteasome
60%
Biological Marker
40%
Immunohistochemistry
20%
Clinical Trial
20%
DNA Damage
20%
Clinical Study
20%
Chymotrypsin
20%
Biochemistry, Genetics and Molecular Biology
DNA Topoisomerase
100%
Topoisomerase
100%
Proteasome
75%
DNA Damage
25%
Clinical Study
25%
Clinical Trial
25%
Chymotrypsin
25%